Mirna Therapeutics
Acquired
- Headquarters
- Austin, Texas
- Employees
- 11–50
- Founded
- 2007
- Business Model
- B2B
- Website
- mirnarx.com
- Total Funding
- $76.3M
- Last Round
- $41.8M Series DMay 2015
About
Mirna Therapeutics was a biopharmaceutical company focused on developing microRNA (miRNA)-directed oncology therapies. Founded in 2007 as a spin-off from Asuragen Inc. in Austin, Texas, Mirna was the first company to advance a microRNA-based therapy into clinical trials for cancer treatment. The company completed an IPO on NASDAQ (ticker: MIRN) in October 2015. In 2017, the company merged with Synlogic, Inc., effectively ending its independent operations.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account